Diff Profiles › MTBLS354_0001_00000001

CAP_Cases_vs_Non_CAP_Controls

CAP_Cases vs Non-CAP_Controls

p-value ≤ 0.05 5 significant 2025-09-26 00:00:00 Study: MTBLS354
5 Total Features
5 Significant
0.05 p-value Threshold

Profile details

Identifier
MTBLS354_0001_00000001
Linked study
MTBLS354 — Lipid metabolites as potential diagnostic and prognostic biomarkers for acute community acquired pneumonia
Comparison
CAP_Cases vs Non-CAP_Controls
Group A
Patients diagnosed with community-acquired pneumonia.. This group is crucial for identifying biomarkers specific to CAP.
Group B
Patients without community-acquired pneumonia.. This group serves as the baseline for identifying CAP-specific biomarkers.
Total features tested
5
Significant features
5
p-value threshold
0.05
Ratio threshold (upper)
1.5
Ratio threshold (lower)
1/1.5
Date created
2025-09-26 00:00:00

Top hits

Metabolite ID (InChI Key) Name Direction Ratio p-value
YVYMBNSKXOXSKW-HXUWFJFHSA-N 1-palmitoyl-<em>sn</em>-glycero-3-phosphoethanolamine zwitterion down 0.4269 1.11e-22
JPNPIRVRGLGTRE-YSKCIPFOSA-N LPE 20:4(8<i>Z</i>,11<i>Z</i>,14<i>Z</i>,17<i>Z</i>)/0:0 down 0.3652 2.22e-18
DBHKHNGBVGWQJE-USWSLJGRSA-N lysophosphatidylethanolamine (18:2(9<i>Z</i>,12<i>Z</i>)) zwitterion down 0.3457 4.01e-16
XEVRBOQZSXWGQO-PAUXXPOVSA-N PE 22:6(4<i>Z</i>,7<i>Z</i>,10<i>Z</i>,13<i>Z</i>,16<i>Z</i>,19<i>Z</i>)/0:0 down 0.3592 6.17e-16
BBYWOYAFBUOUFP-JOCHJYFZSA-N 2-azaniumylethyl (2<i>R</i>)-2-hydroxy-3-(stearoyloxy)propyl phosphate down 0.5117 1e-14